Search Results - "Arriaga, Y."

Phase 2 Trial of High-Dose Interleukin-2 (IL-2) and Stereotactic Ablative Radiation Therapy (SABR) for Metastatic Clear Cell Renal Cell Carcinoma (mRCC)—Interim Analysis of i-SAbR IL-2 Trial by Ishihara, D, Louder, K, Akter, M, Ahn, C, Margulis, V, Arriaga, Y, Courtney, K, Timmerman, R.D, Brugarolas, J, Hannan, R

Get full text

Routine Use of Concurrent Radiation Therapy and Chemotherapy in HIV-Positive Patients With Squamous Cell Anal Cancer: Toxicity and Local Control Outcomes by Wang, C.J, Arriaga, Y, Karri, S, Verma, U, Beg, M.S, Olson, C, Anandam, J, Abdelnaby, A, Balch, G, Meyer, J.J

Get full text

Preliminary Results From a Phase I Trial of Radiation Therapy, Capecitabine, and the Phosphatidylserine-Targeting Antibody Bavituximab in the Neoadjuvant Treatment of Rectal Adenocarcinoma by Meyer, J.J, Arriaga, Y, Anandam, J, Karri, S, Verma, U, Abdelnaby, A, Raja, G, Dong, Y, Beg, M.S, Shan, J, Balch, G

Get full text

Shorter bevacizumab infusions do not increase the incidence of proteinuria and hypertension by Shah, S.R., Gressett Ussery, S.M., Dowell, J.E., Marley, E., Liticker, J., Arriaga, Y., Verma, U.

“…A previous study has shown that shorter bevacizumab infusions (0.5 mg/kg/min) can be safely administered without increasing the risk of infusion-related…”
Get full text

253 Phase 1 correlative study of ARQ761, a β-lapachone analogue that promotes NQ01-mediated programmed cancer cell necrosis by Gerber, D, Arriaga, Y, Beg, M.S, Dowell, J.E, Schiller, J.H, Frankel, A.E, Leff, R, Meek, C, Bolluyt, J, Fatunde, O, Martinez, R.T, Vo, P, Fattah, F, Sarode, V, Zhou, Y, Xie, Y, McLeod, M, Schwartz, B, Boothman, D.A

Get full text

Neurotology Telemedicine Consultation by Arriaga, Moisés, MD, MBA, Nuss, Daniel, MD, Arriaga, Rebecca Y., M Litt

“…The opportunity to treat neurotologic patients when the patient and physician are in separate locations is an important clinical delivery mechanism. The…”
Get full text

Oxidation in Water Vapor of Inconel 625 Fabricated by Additive Manufacturing by Pineda-Arriaga, Karen Y, Ramírez-Ramírez, Javier H, Pérez-González, Francisco A, Alvarado-Orozco, Juan M, Colás Rafael, Garza-Montes-de-Oca, Nelson F

“…The high-temperature oxidation characteristics of Inconel 625 superalloy fabricated by additive manufacturing were studied at 900 and 1000 °C in a mixture of…”
Get full text

Surface and Subsurface Defects Formed in a Cold-Rolled Electrical Steel by Garza-Montes-de-Oca, Nelson F., Pineda-Arriaga, Karen Y., Gaona-Martínez, Mauro J., Ramírez-Ramírez, Javier H., Pérez-González, Francisco A., Colás, Rafael

“…The causes for the formation of defects of different characteristics on an electrical-grade cold-rolled steel strip surface are presented. Inspection of…”
Get full text

496P Factors associated with colorectal cancer in patients 18 to 50 years old in the United States by Arriaga, Y., Huang, H., Wang, S., Scheufele, E., Rhee, K., Jackson, G., Mullan, I. Dankwa

Get full text

Contribution of individual disulfide bonds to biological action of Escherichia coli heat-stable enterotoxin B by Arriaga, Y.L. (University of Missouri-Kansas City, Kansas City, MO.), Harville, B.A, Dreyfus, L.A

“…Heat-stable enterotoxins (STs) of Escherichia coli are peptides which alter normal gut physiology by stimulating the loss of water and electrolytes. The action…”
Get full text

708P - A phase I/Ib, multi-center trial of ARQ-761 (Beta-Lapachone) with gemcitabine/nab-paclitaxel in patients with advanced pancreatic cancer by Beg, M.S., Boothman, D., Khosama, L., Arriaga, Y., Verma, U., Sanjeeviaiah, A., Kazmi, S., Fattah, F., Pilarski, S., Rodriguez, M., Lindsey, D., Linden, S., Schwartz, B., Laheru, D.

“…ARQ761 (β-lapachone) is a hydroquinone analog that exploits the unique elevation of NQO1 found in 90% of pancreatic cancer cells and causes tumor-specific cell…”
Get full text

A phase I/Ib, multi-center trial of ARQ-761 (Beta-Lapachone) with gemcitabine/nab-paclitaxel in patients with advanced pancreatic cancer by Beg, M.S., Boothman, D., Khosama, L., Arriaga, Y., Verma, U., Sanjeeviaiah, A., Kazmi, S., Fattah, F., Pilarski, S., Rodriguez, M., Lindsey, D., Linden, S., Schwartz, B., Laheru, D.

Get full text

708PA phase I/Ib, multi-center trial of ARQ-761 (Beta-Lapachone) with gemcitabine/nab-paclitaxel in patients with advanced pancreatic cancer by Beg, M S, Boothman, D, Khosama, L, Arriaga, Y, Verma, U, Sanjeeviaiah, A, Kazmi, S, Fattah, F, Pilarski, S, Rodriguez, M, Lindsey, D, Linden, S, Schwartz, B, Laheru, D

“…Abstract Background ARQ761 (β-lapachone) is a hydroquinone analog that exploits the unique elevation of NQO1 found in 90% of pancreatic cancer cells and causes…”
Get full text

Characterization of the High-Temperature Oxidation Behavior of Inconel 625® Fabricated by Additive Manufacturing and Conventional Methods by Pineda-Arriaga, Karen Y., Ramírez-Ramírez, Javier H., Pérez-González, Francisco A., Alvarado-Orozco, Juan M., Colás, Rafael, Garza-Montes-de-Oca, Nelson F.

“…The differences between the isothermal oxidation behavior of the Inconel 625 ® superalloy fabricated by additive manufacturing and wrought conditions are…”
Get full text

Safety and Outcomes of Combining Immune Checkpoint Inhibitors with Radiation Therapy by Mohamad, O., Leiker, A., Schroeder, S., Zhang, E., Trivedi, L., Gerber, D., Khan, S., Iyengar, P., Albuquerque, K.V., Arriaga, Y., Courtney, K., Brugarolas, J., Hammers, H., Timmerman, R.D., Hannan, R.

Get full text

Subgroup analysis of patients with metastatic colorectal cancer (mCRC) treated with regorafenib (REG) in the phase 3b CONSIGN trial who had progression-free survival (PFS) >4 months (m) by Garcia-Carbonero, R., Van Cutsem, E., Ciardiello, F., Ychou, M., Seitz, J.-F., Hofheinz, R.D., Arriaga, Y., Verma, U., Grothey, A., Miriyala, A., Kalmus, J., Kappeler, C., Falcone, A., Zaniboni, A.

Get full text

PD-012Analysis of patients ≥75 years in the open-label phase 3b CONSIGN trial of regorafenib in previously treated metastatic colorectal cancer (mCRC) by Van Cutsem, E., Ciardiello, F., Ychou, M., Seitz, J.-F., Hofheinz, R., Arriaga, Y., Garcia-Carbonero, R., Grothey, A., Miriyala, A., Kalmus, J., Kappeler, C., Falcone, A., Zaniboni, A.

Get full text

PD-012 Analysis of patients ≥75 years in the open-label phase 3b CONSIGN trial of regorafenib in previously treated metastatic colorectal cancer (mCRC) by Van Cutsem, E., Ciardiello, F., Ychou, M., Seitz, J.-F., Hofheinz, R., Arriaga, Y., Garcia-Carbonero, R., Grothey, A., Miriyala, A., Kalmus, J., Kappeler, C., Falcone, A., Zaniboni, A.

Get full text

PD-012Analysis of patients greater than or equal to 75 years in the open-label phase 3b CONSIGN trial of regorafenib in previously treated metastatic colorectal cancer (mCRC) by Van Cutsem, E, Ciardiello, F, Ychou, M, Seitz, J-F, Hofheinz, R, Arriaga, Y, Garcia-Carbonero, R, Grothey, A, Miriyala, A, Kalmus, J, Kappeler, C, Falcone, A, Zaniboni, A

Get full text

Visually Enhanced Vestibulo-Ocular Reflex: A Diagnostic Tool for Migraine Vestibulopathy by Arriaga, Moisés A., Chen, Douglas A., Hillman, Todd A., Kunschner, Lara, Arriaga, Rebecca Y.

“…Objectives: 1) To compare the incidence of elevated visually enhanced vestibular‐ocular reflex (VVOR) rotational gain during rotational chair testing in a…”
Get full text